"The Report Global Thalassemia Market Report: 2016 Edition provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Albany, NY -- (SBWIRE) -- 06/02/2016 -- Thalassemia is a hereditary blood disorder in which a person's body makes an abnormal form of hemoglobin, which is the protein molecule in red blood cells (RBCs), which carries oxygen. The disorder results in unwarranted damage of red blood cells, which leads to anemia. Anemia is a condition in which the body doesn't have adequate amount of normal and healthy red blood cells. There are majorly two types of thalassemia based on these proteins known as the Alpha thalassemia and the Beta thalassemia. There is also a third type viz. Sickle beta thalassemia, which is like a combination of sickle cell disease and beta thalassemia.
View Full Report at: http://www.marketresearchreports.biz/analysis/725246
Even though it is a rare genetic disorder, the number of people affected by it has been growing with time. While those with thalassemia minor have hardly any threat to their life and only require occasional blood transfusion to sustain, thalassemia major patients need to go for periodic transfusions for a sustained life. In case of infants, thalassemia major often leads to still birth or cause death shortly after the baby's birth. Presently the only cure for thalassemia is a bone marrow transplantation therapy, which is done mostly for severe cases of thalassemia.
The key factors which are anticipated to drive this market include rising healthcare expenditure, rising spending on stem cell therapy research and development and rising population in the East-Asia and Pacific region of the world. Some of the noteworthy developments of this industry include the advances in the iron chelation therapy, development of gene therapy and fetal hemoglobin inducers as potential curatives for thalassemia. However, the growth of respective industry is challenged by the high cost of treatments, lack of alternative treatments and unmet market of the Asia-Pacific.
Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/725246
The report provides a comprehensive study of global thalassemia market and also major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. The global thalassemia industry is highly competitive consisting of several companies including the Lonza group, Acceleron Pharma, BlueBird Bio and Sangamo Biosciences etc. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.
Table of Content
1.2 Types of Thalassemia
1.2.1 Alpha Thalassemia
1.2.2 Beta Thalassemia
1.2.3 Sickle Beta Thalassemia
1.3 Signs and Symptoms
1.4 Treatment Options
1.4.1 Blood Transfusion
1.4.2 Bone Marrow Transplant
2. Global Thalassemia Market
2.1 Global Thalassemia Incidence by Severity
2.2 Global Thalassemia Diagnosis by Category
2.3 Global Transfusion-Dependent ? Thalassemia by Region
2.4 Global Thalassemia Market by Therapy
2.4.1 Global Bone Marrow Transplant Revenue
2.4.2 Global LentiGlobin BB305 Revenue
2.4.3 Global Luspatercept Revenue
3. Regional Analysis
3.1 The US Thalassemia Market
3.1.1 The US ? Thalassemia Carrier Patient Population
3.1.2 The US ? Thalassemia Major Patient Population
3.1.3 The US Transfusion-Dependent ? Thalassemia Patients
3.1.4 The US ? Thalassemia Sibling-Matched Stem Cell Transplant
3.2 Europe Thalassemia Market
3.2.1 Europe Transfusion-Dependent ? Thalassemia Patients
3.2.2 Europe Transfusion-Dependent ?-Thalassemia Major/Intermediate Patients
Browse all latest Press Releases of Market Research Reports at: http://www.marketresearchreports.biz/pressreleases
MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.
90 Sate Street,
Suite 700 Albany,
NY 12207 USA
Canada Toll Free: 866-997-4948